The legacy of Viagra and its creator , copyright, presents a tangled picture for potential investors. While the iconic drug initially fueled enormous revenues , its patent has lapsed , leading to competing alternatives flooding the arena. This reduction in pricing presents a real obstacle for copyright and any company considering a heavy stake in t